乐卡地平结构式
|
常用名 | 乐卡地平 | 英文名 | Lercanidipine |
|---|---|---|---|---|
| CAS号 | 100427-26-7 | 分子量 | 611.727 | |
| 密度 | 1.2±0.1 g/cm3 | 沸点 | 712.5±60.0 °C at 760 mmHg | |
| 分子式 | C36H41N3O6 | 熔点 | 118-120ºC | |
| MSDS | N/A | 闪点 | 384.7±32.9 °C |
乐卡地平用途Lercanidipine是钙离子通道阻断剂。 |
| 中文名 | 乐卡地平 |
|---|---|
| 英文名 | 5-O-[1-[3,3-diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
| 中文别名 | 1,4-双氢-2,6-二甲基-4-(3-硝基苯基)-3,5-吡啶二羧酸 2-[(3,3-二苯丙基)甲氨基]-1,1-二甲基乙基甲酯 |
| 英文别名 | 更多 |
| 描述 | Lercanidipine是钙离子通道阻断剂。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 密度 | 1.2±0.1 g/cm3 |
|---|---|
| 沸点 | 712.5±60.0 °C at 760 mmHg |
| 熔点 | 118-120ºC |
| 分子式 | C36H41N3O6 |
| 分子量 | 611.727 |
| 闪点 | 384.7±32.9 °C |
| 精确质量 | 611.299561 |
| PSA | 113.69000 |
| LogP | 8.04 |
| 外观性状 | 白色至淡黄色固体 |
| 蒸汽压 | 0.0±2.3 mmHg at 25°C |
| 折射率 | 1.580 |
| 海关编码 | 2942000000 |
|---|
|
~76%
乐卡地平 100427-26-7 |
| 文献:Recordati Ireland Limited Patent: US2006/199849 A1, 2006 ; Location in patent: Page/Page column 7-8 ; |
|
~%
乐卡地平 100427-26-7 |
| 文献:European Journal of Medicinal Chemistry, , vol. 33, # 5 p. 399 - 420 |
|
~%
乐卡地平 100427-26-7 |
| 文献:European Journal of Medicinal Chemistry, , vol. 33, # 5 p. 399 - 420 |
|
~%
乐卡地平 100427-26-7 |
| 文献:European Journal of Medicinal Chemistry, , vol. 33, # 5 p. 399 - 420 |
|
~%
乐卡地平 100427-26-7 |
| 文献:European Journal of Medicinal Chemistry, , vol. 33, # 5 p. 399 - 420 |
|
~%
乐卡地平 100427-26-7 |
| 文献:European Journal of Medicinal Chemistry, , vol. 33, # 5 p. 399 - 420 |
|
~%
乐卡地平 100427-26-7 |
| 文献:US2006/199849 A1, ; Page/Page column 8 ; |
|
~%
乐卡地平 100427-26-7 |
| 文献:European Journal of Medicinal Chemistry, , vol. 33, # 5 p. 399 - 420 |
| 乐卡地平上游产品 9 | |
|---|---|
| 乐卡地平下游产品 1 | |
| 海关编码 | 2942000000 |
|---|
| 1-[(3,3-diphenylpropyl)(methyl)amino]-2-methylpropan-2-yl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
| 3-O-[1-[3,3-diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] 5-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
| 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic Acid 2-[(3,3-Diphenylpropyl)methylamino]-1,1-dimethylethyl Methyl Ester |
| lercarnidipine |
| 3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-[(3,3-diphenylpropyl)methylamino]-1,1-dimethylethyl methyl ester |
| methyl 1,1,N-trimethyl-N-(3,3-diphenylpropyl)-2-aminoethyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-pyridine-3,5-dicarboxylate |
| masnidipine |
| Methyl 1,1-Dimethyl-2-[N-(3,3-diphenylpropyl)-N-methylamino]ethyl 2,6-Dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
| 1-[(3,3-Diphenylpropyl)(methyl)amino]-2-methyl-2-propanyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate |
| Lercanidipine [INN] |
| UNII:V7XTJ4R0BH |
| Lercanil (TN) |
| (±)-2-((3,3-diphenylpropyl)(methyl)amino)-1,1-dimethylethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate |
| REC 15-2375 |
| MFCD00867978 |
| UNII-V7XTJ4R0BH |
| 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinecarboxylic acid 2-[(3,3-diphenylpropyl)methylamino]-1,1-dimethylethyl methyl ester |
| Lercanidipine |